Skip to main content
Signal8

Gilead Prices $3 Billion of Senior Unsecured Notes

$GILDPress releaseMay 14, 2026, 9:21 PM ETRead the release

Gilead Sciences priced a $3 billion offering of senior unsecured notes across four tranches maturing between 2028 and 2034. The weighted average interest rates range from 4.25% to 4.90%, reflecting current market conditions for investment-grade biopharma debt.

Key figures

Deal Value Usd
3000000000
Note 2028 rate
4.250%
Note 2029 rate
4.400%
Note 2031 rate
4.600%
Note 2034 rate
4.900%
Note 2028 amount
500000000
Note 2029 amount
1000000000
Note 2031 amount
1000000000
Note 2034 amount
500000000

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.